The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster medications.
CEO Daniel Schulman, who formerly headed PayPal’s global transformation and Virgin Mobile’s $483 million sale, looks to turn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback